UBS raised the firm’s price target on Molina Healthcare (MOH) to $180 from $151 and keeps a Neutral rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare price target raised to $146 from $128 at Morgan Stanley
- Molina Healthcare price target raised to $161 from $133 at Barclays
- Molina Healthcare Earnings Call Balances Strength And Risk
- Closing Bell Movers: Tesla reverses post-earnings gains, IBM slips after Q1
- Molina Healthcare reports Q1 EPS $2.35, consensus $1.94